Changeflow GovPing

What do you monitor?

Curated feeds for your role. Pick your area and get exactly the sources you need.

Recent changes

Favicon for taxfoundation.org

North Carolina Property Tax Reform Analysis

The Tax Foundation analyzes North Carolina's property tax system, arguing that levy limits protect taxpayers from rapidly rising property valuations. The analysis suggests reforms should preserve the property tax base while addressing recent pressures on homeowners.

Routine Notice Taxation
8d ago ECB Press Releases
Favicon for www.ecb.europa.eu

ECB Presentation on Euro Area Economy Scenarios

The European Central Bank (ECB) released a presentation outlining baseline and alternative scenarios for the euro area economy, focusing on the impact of uncertainty, fiscal policies, and energy supply disruptions. The presentation includes projections for GDP growth and inflation under various scenarios, with a cut-off date of March 11, 2026.

Routine Notice Banking
8d ago ECB Press Releases
Favicon for www.ecb.europa.eu

ECB Speech: Navigating Energy Shocks and Policy Responses

ECB President Christine Lagarde delivered a speech on navigating energy shocks and policy responses. The speech outlined the ECB's monetary policy strategy for assessing and responding to economic shocks, emphasizing a data-driven approach based on the nature, size, and persistence of shocks.

Priority review Notice Financial Services
Favicon for courts.delaware.gov

Mangle v. Inspirit Senior Living - Summary Judgment Denied

The Delaware Superior Court denied a motion for summary judgment filed by Inspirit Senior Living and Kent Landscaping in a personal injury lawsuit. The case involves a slip and fall incident allegedly caused by snow and ice removal negligence.

Routine Enforcement Judicial Administration
Favicon for changeflow.com

EPO Patent Publication: Hydroquinazoline Derivatives for Disease Treatment

The European Patent Office has published patent application EP4673431A1 for Novartis AG, detailing hydroquinazoline derivatives for treating diseases or disorders. The publication includes a list of inventors and IPC classifications related to chemical compounds and their therapeutic applications.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application: Silicon Nanoparticles for Kidney Disease Treatment

The European Patent Office has published a patent application (EP4495059A2) for Osaka University concerning silicon nanoparticles for use in treating kidney diseases. The application details specific IPC classifications related to pharmaceutical compositions and therapeutic uses.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

Translate Bio mRNA Patent EP4529928A2 Publication

The European Patent Office has published patent application EP4529928A2 concerning mRNA compositions, methods, and uses, filed by Translate Bio, Inc. The patent is scheduled for publication on March 18, 2026, and covers various applications including cancer treatment.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Bulletin: Assays for Diagnosing Fabry Disease Treatment Options

The European Patent Office has published patent application EP4541418A2 concerning assays for diagnosing and evaluating treatment options for Fabry disease. The application lists Amicus Therapeutics, Inc. and the National Institutes of Health as applicants.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent Application: Metformin and Sitagliptin Tablet Formulation

The European Patent Office published patent application EP4563143A1 concerning a bilayer tablet formulation of Metformin and Sitagliptin that includes an antioxidant. The application was filed by Sanovel Ilac Sanayi ve Ticaret A.S. and lists Fatih Sunel, Nur Pehlivan Akalin, and Guldeniz Tunc as inventors.

Routine Notice Pharmaceuticals
Favicon for changeflow.com

EPO Patent: Neural Disorder Treatment via Plasminogen Cascade Modulation

The European Patent Office has published a patent application (EP2024194382A1) detailing methods for preventing or treating neural disorders by modulating the plasminogen-plasmin cascade. The patent application was published on March 18, 2026, and covers designated states within the European Union.

Routine Notice Pharmaceuticals

Showing 13051–13060 of 36,970 changes

1 1304 1305 1306 1307 1308 3697

Get alerts when regulations change

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.